Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis (the European Breast Guidelines) for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.

The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care). 

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Privacy statement

Members and external experts

Back

Holger J. Schünemann

Holger J. Schünemann

GDG co-chair of methodology

Dr. Schünemann is chair of the Department of Clinical Epidemiology and Biostatistics at McMaster University, widely considered the birthplace of evidence-based medicine. He trained in internal medicine, epidemiology, preventive medicine and public health.

Having contributed to over 400 peer-reviewed publications (across a broad area of health care questions) he is co-chair of the GRADE working group, co-director of the World Health Organization (WHO) collaborating center for evidence informed policy-making, a member of the Board of Trustees of the Guideline International Network, the Cochrane Collaboration Steering Group, and several other committees.

He led or participated in numerous high profile guideline panels, including at the WHO, the American College of Physicians, American Thoracic Society, the World Allergy Organization and he was a key contributor to the revised methods for WHO guideline development in 2006.

For the past 15 years, he has been advisor to ministries of health and other governmental organizations for their guideline programs.

His work also focuses on practical application of his work by researchers and clinicians through contributions to the guideline development tool, the guideline checklist and GRADE evidence to decision frameworks. Maintaining an active clinical practice fulfills his passion for patient care and ensures his research is people-oriented.

In his personal life, he has planned to ride the course of a Tour de France, trains vigorously and succeeded partially.

Declaration of interests



Last update: 2018